Autolus Therapeutics plc (AUTL)

NASDAQ: AUTL · Real-Time Price · USD

1.420

+0.100 (7.58%)

At close: Feb 6, 2026, 4:00 PM EST

1.408

-0.012 (-0.82%)

After-hours: Feb 6, 2026, 7:59 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017	Sep '16 Sep 30, 2016
Chimeric Antigen Receptors T Cell Therapies	10.12M
Chimeric Antigen Receptors T Cell Therapies Growth	496.00%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017	Sep '16 Sep 30, 2016
Europe	10.12M